JP2009215293A - 食物なしでジプラシドンを投与するための方法、剤形、およびキット - Google Patents

食物なしでジプラシドンを投与するための方法、剤形、およびキット Download PDF

Info

Publication number
JP2009215293A
JP2009215293A JP2009052853A JP2009052853A JP2009215293A JP 2009215293 A JP2009215293 A JP 2009215293A JP 2009052853 A JP2009052853 A JP 2009052853A JP 2009052853 A JP2009052853 A JP 2009052853A JP 2009215293 A JP2009215293 A JP 2009215293A
Authority
JP
Japan
Prior art keywords
ziprasidone
dosage form
human
oral dosage
solid oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009052853A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009215293A5 (enExample
Inventor
William John Curatolo
ジョン クラトロ ウィリアム
Scott Max Herbig
マックス ハービッグ スコット
Avinash Govind Thombre
ゴヴィンド ソムブレ アヴィナッシュ
Jaymin Chandrakant Shah
チャンドラカント シャフ ジャイミン
Sheri Lynn Shamblin
リン シャンブリン シェリ
Timothy LUKAS
ルーカス ティモシー
William Caldwell Brett
ブレット カルドウェル ウィリアム
Dwayne Thomas Friesen
トーマス フリーセン ドウェイン
David Keith Lyon
キース リオン デイヴィッド
Christopher Donovan Craig
ドノヴァン クライグ クリストファー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of JP2009215293A publication Critical patent/JP2009215293A/ja
Publication of JP2009215293A5 publication Critical patent/JP2009215293A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2009052853A 2008-03-07 2009-03-06 食物なしでジプラシドンを投与するための方法、剤形、およびキット Withdrawn JP2009215293A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3494708P 2008-03-07 2008-03-07

Publications (2)

Publication Number Publication Date
JP2009215293A true JP2009215293A (ja) 2009-09-24
JP2009215293A5 JP2009215293A5 (enExample) 2012-04-12

Family

ID=40720011

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009052853A Withdrawn JP2009215293A (ja) 2008-03-07 2009-03-06 食物なしでジプラシドンを投与するための方法、剤形、およびキット

Country Status (15)

Country Link
US (1) US20110002989A1 (enExample)
EP (1) EP2280711A1 (enExample)
JP (1) JP2009215293A (enExample)
KR (1) KR20100131477A (enExample)
CN (1) CN102014910A (enExample)
AR (1) AR070964A1 (enExample)
AU (1) AU2009220925A1 (enExample)
BR (1) BRPI0909818A2 (enExample)
CA (1) CA2719115A1 (enExample)
IL (1) IL207792A0 (enExample)
MX (1) MX2010009844A (enExample)
RU (1) RU2010135831A (enExample)
TW (1) TW200950783A (enExample)
WO (1) WO2009109844A1 (enExample)
ZA (1) ZA201005905B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019112416A (ja) * 2013-05-03 2019-07-11 シンダックス ファーマシューティカルズ，インク． 癌の処置方法

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010082855A1 (en) * 2009-01-15 2010-07-22 Zaklady Farmaceutyczne Polpharma Sa Pharmaceutical compositions comprising ziprasidone free base or ziprasidone hydrochloride and the method for their preparation
US9510148B2 (en) * 2009-03-03 2016-11-29 Mobilitie, Llc System and method for wireless communication to permit audience participation
PL3027171T3 (pl) 2013-07-30 2020-08-24 Gilead Connecticut, Inc. Formulacja inhibitorów syk
EA029281B1 (ru) 2013-07-30 2018-03-30 Джилид Коннектикут, Инк. Полиморф ингибиторов syk
CA2928772A1 (en) * 2013-12-05 2015-06-11 Alrise Biosystems Gmbh Process for the production of drug formulations for oral administration
TWI662037B (zh) 2013-12-23 2019-06-11 美商基利科學股份有限公司 脾酪胺酸激酶抑制劑
US10474345B2 (en) * 2014-04-04 2019-11-12 Shawn SHEY User interfaces and methods for displaying content
CN106714785A (zh) * 2014-09-19 2017-05-24 宝洁公司 用于制备具有活性包衣的芯的方法
WO2016198983A1 (en) 2015-06-09 2016-12-15 Bend Research Inc. Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules
CA2987081C (en) 2015-06-11 2022-08-30 Alrise Biosystems Gmbh Process for the preparation of drug loaded microparticles
CN107714669A (zh) * 2016-08-11 2018-02-23 广东东阳光药业有限公司 齐拉西酮缓释剂及其制备方法
KR20220070056A (ko) 2017-08-25 2022-05-27 길리애드 사이언시즈, 인코포레이티드 Syk 억제제의 다형체
AU2020225455A1 (en) 2019-02-22 2021-09-09 Kronos Bio, Inc. Solid forms of condensed pyrazines as Syk inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003000226A2 (en) * 2001-06-22 2003-01-03 Pfizer Products Inc. Pharmaceutical compositions containing polymer and drug assemblies
KR20060115350A (ko) * 2003-09-02 2006-11-08 화이자 프로덕츠 인크. 지프라시돈의 지속 방출형 투여 형태
US7825106B2 (en) * 2003-09-03 2010-11-02 Agi Therapeutics Ltd. Modified release formulations and methods of treating inflammatory bowel disease
EP1703898A2 (en) * 2003-12-31 2006-09-27 Alpharma, Inc. Ziprasidone formulations
EP1753400A4 (en) * 2004-06-11 2012-11-28 Reddys Lab Ltd Dr PHARMACEUTICAL FOR ZIPRASIDONE
KR20080024206A (ko) * 2005-06-20 2008-03-17 엘란 파마 인터내셔널 리미티드 아릴-헤테로시클릭 화합물을 함유하는 나노입자형 조절방출 조성물

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019112416A (ja) * 2013-05-03 2019-07-11 シンダックス ファーマシューティカルズ，インク． 癌の処置方法

Also Published As

Publication number Publication date
AR070964A1 (es) 2010-05-19
US20110002989A1 (en) 2011-01-06
BRPI0909818A2 (pt) 2015-10-06
CN102014910A (zh) 2011-04-13
MX2010009844A (es) 2010-09-30
EP2280711A1 (en) 2011-02-09
CA2719115A1 (en) 2009-09-11
ZA201005905B (en) 2011-11-30
RU2010135831A (ru) 2012-04-20
WO2009109844A1 (en) 2009-09-11
AU2009220925A1 (en) 2009-09-11
TW200950783A (en) 2009-12-16
KR20100131477A (ko) 2010-12-15
IL207792A0 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
US12447128B2 (en) Formulations of enzalutamide
US20110002989A1 (en) Methods, dosage forms and kits for administering ziprasidone without food
RU2351316C2 (ru) Лекарственные формы с замедленным высвобождением зипразидона
KR20160113294A (ko) 안드로겐 수용체 길항제의 고체 제약 조성물
JP2011516613A (ja) 好ましくはポサコナゾールおよびｈｐｍｃａｓを含む固体分散物中の経口用薬学的組成物
HK1150392A (en) Methods, dosage forms, and kits for administering ziprasidone without food
HK40108713A (en) Formulations of enzalutamide
HK40116766A (en) Formulations of enzalutamide
HK40065232A (en) Formulations of enzalutamide
HK40037883A (en) Formulations of enzalutamide
HK40037883B (en) Formulations of enzalutamide

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120229

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120229

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20121001